ArticleNature communications2026
AlphaGEM enables precise genome-scale metabolic modelling by integrating protein structure alignment with deep-learning-based dark metabolism mining.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- LumbriCyc: towards metabolic modelling of earthworms.NPJ systems biology and applications · 2026Article
- Metabolic modeling of host-microbe interactions.Computational and structural biotechnology journal · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Constructing high-quality genome-scale metabolic models (GEMs) for non-model organisms remains challenging. To address this, we developed AlphaGEM, a versatile toolbox leveraging proteome-scale structural alignment, protein language models (PLMSearch), and deep-learning-based predictions for efficient genomic mining to generate GEMs ready for applications. AlphaGEM enhances homologous relationship identification compared to traditional sequence-based methods. Crucially, it employs an ensemble procedure empowered by multiple deep learning toolboxes to effectively mine dark metabolic functions encoded by nonhomologous proteins, thereby expanding species-specific networks. We validated AlphaGEM across prokaryotes (Klebsiella pneumoniae, Bacillus subtilis), eukaryotes (Rhodosporidium toruloides, Pichia pastoris), and complex mammals (Mus musculus, Cricetulus griseus), achieving predictions comparable to manually curated models while outperforming existing tools. Furthermore, we demonstrated its scalability by automatically reconstructing high-fidelity GEMs for 332 distinct yeast species. In summary, AlphaGEM enables precise, rapid GEM construction across diverse domains, providing a solid foundation for universal functional analysis of organisms having genome sequences available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.